Continuous glucose monitoring devices: A brief presentation (Review)

As diabetes prevalence is continuously increasing, better management is needed to achieve blood glucose control, in order to prevent complications and lessen the burden of this disease. Since the first measurement of glycosuria at the beginning of the 1900s', huge advances were made in monitori...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental and therapeutic medicine 2022-02, Vol.23 (2), p.174, Article 174
Hauptverfasser: Mihai, Doina Andrada, Stefan, Diana Simona, Stegaru, Daniela, Bernea, Georgiana Elena, Vacaroiu, Ileana Adela, Papacocea, Toma, Lupușoru, Mircea Ovidiu Denis, Nica, Adriana Elena, Stiru, Ovidiu, Dragos, Dorin, Olaru, Octavian Gabriel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 174
container_title Experimental and therapeutic medicine
container_volume 23
creator Mihai, Doina Andrada
Stefan, Diana Simona
Stegaru, Daniela
Bernea, Georgiana Elena
Vacaroiu, Ileana Adela
Papacocea, Toma
Lupușoru, Mircea Ovidiu Denis
Nica, Adriana Elena
Stiru, Ovidiu
Dragos, Dorin
Olaru, Octavian Gabriel
description As diabetes prevalence is continuously increasing, better management is needed to achieve blood glucose control, in order to prevent complications and lessen the burden of this disease. Since the first measurement of glycosuria at the beginning of the 1900s', huge advances were made in monitoring glycemia. Continuous glucose monitoring systems revolutionized diabetes management, especially for patients with type 1 diabetes. Avoiding glycemic variability and maintaining optimal glycemic control is crucial for the evolution of patients with type 1 diabetes. The usefulness of glycemic monitoring devices can be extended to patients with type 2 diabetes. It is also important to note that in those patients at risk of developing high glycemic variability (e.g. patients with advanced chronic kidney disease), continuous glycemic monitoring may improve their prognosis. These monitoring systems can be classified according to the analytical method, the degree of invasiveness, the data availability and the mode of usage. The technology is constantly improving in bioanalytical performance, biocompatibility, length of wearing time, safety and clinical features. The aim of this review was to briefly present the main characteristics of glucose biosensors, glucose monitoring systems and their clinically utility.
doi_str_mv 10.3892/etm.2021.11097
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8764584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A695354839</galeid><sourcerecordid>A695354839</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-7c9ae6abff8423379b502252d366f758e29f74cb074d5f1b0261d299a11ece953</originalsourceid><addsrcrecordid>eNptkctLXDEUxoO0VLFuu5QL3bSLGfO4eXUhDOOjgiBIXYfc3JNpZG4yJvda-t8b66gVzFkknPOdjy_8EPpC8JwpTY9gHOYUUzInBGu5g_aI1HRGMOEftm-sFdlFB6Xc4nq4IErxT2iXcSy04nwPnSxTHEOc0lSa1XpyqUAzpBjGlENcNT3cBwflR7NouhzAN5sMBeJox5Bi8-26juHP98_oo7frAgfbex_dnJ3-Wv6cXV6dXywXlzPXEj7OpNMWhO28Vy1lTOqOY0o57ZkQXnIFVHvZug7LtueedJgK0lOtLSHgQHO2j46ffDdTN0DvapBs12aTw2DzX5NsMG8nMfw2q3RvlBQtV201-Lo1yOlugjKa2zTlWDMbKihTTAopX1UruwYTok_VzA2hOLMQNQZvFdNVNX9HVauHIbgUwYfaf2_B5VRKBv8SnGDzyNNUnuaRp_nHsy4c_v_dF_kzPfYAjzOaUA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2623837677</pqid></control><display><type>article</type><title>Continuous glucose monitoring devices: A brief presentation (Review)</title><source>PubMed Central</source><creator>Mihai, Doina Andrada ; Stefan, Diana Simona ; Stegaru, Daniela ; Bernea, Georgiana Elena ; Vacaroiu, Ileana Adela ; Papacocea, Toma ; Lupușoru, Mircea Ovidiu Denis ; Nica, Adriana Elena ; Stiru, Ovidiu ; Dragos, Dorin ; Olaru, Octavian Gabriel</creator><creatorcontrib>Mihai, Doina Andrada ; Stefan, Diana Simona ; Stegaru, Daniela ; Bernea, Georgiana Elena ; Vacaroiu, Ileana Adela ; Papacocea, Toma ; Lupușoru, Mircea Ovidiu Denis ; Nica, Adriana Elena ; Stiru, Ovidiu ; Dragos, Dorin ; Olaru, Octavian Gabriel</creatorcontrib><description>As diabetes prevalence is continuously increasing, better management is needed to achieve blood glucose control, in order to prevent complications and lessen the burden of this disease. Since the first measurement of glycosuria at the beginning of the 1900s', huge advances were made in monitoring glycemia. Continuous glucose monitoring systems revolutionized diabetes management, especially for patients with type 1 diabetes. Avoiding glycemic variability and maintaining optimal glycemic control is crucial for the evolution of patients with type 1 diabetes. The usefulness of glycemic monitoring devices can be extended to patients with type 2 diabetes. It is also important to note that in those patients at risk of developing high glycemic variability (e.g. patients with advanced chronic kidney disease), continuous glycemic monitoring may improve their prognosis. These monitoring systems can be classified according to the analytical method, the degree of invasiveness, the data availability and the mode of usage. The technology is constantly improving in bioanalytical performance, biocompatibility, length of wearing time, safety and clinical features. The aim of this review was to briefly present the main characteristics of glucose biosensors, glucose monitoring systems and their clinically utility.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2021.11097</identifier><identifier>PMID: 35069855</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Acids ; Biosensors ; Blood sugar monitoring ; Diabetes ; Electrodes ; Enzymes ; Glucose monitoring ; Glucose monitors ; Graphene ; Methods ; Nanoparticles ; Physiology ; Review ; Sensors ; Technology application ; Urine</subject><ispartof>Experimental and therapeutic medicine, 2022-02, Vol.23 (2), p.174, Article 174</ispartof><rights>Copyright: © Mihai et al.</rights><rights>COPYRIGHT 2022 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2022</rights><rights>Copyright: © Mihai et al. 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-7c9ae6abff8423379b502252d366f758e29f74cb074d5f1b0261d299a11ece953</citedby><cites>FETCH-LOGICAL-c415t-7c9ae6abff8423379b502252d366f758e29f74cb074d5f1b0261d299a11ece953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764584/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764584/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35069855$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mihai, Doina Andrada</creatorcontrib><creatorcontrib>Stefan, Diana Simona</creatorcontrib><creatorcontrib>Stegaru, Daniela</creatorcontrib><creatorcontrib>Bernea, Georgiana Elena</creatorcontrib><creatorcontrib>Vacaroiu, Ileana Adela</creatorcontrib><creatorcontrib>Papacocea, Toma</creatorcontrib><creatorcontrib>Lupușoru, Mircea Ovidiu Denis</creatorcontrib><creatorcontrib>Nica, Adriana Elena</creatorcontrib><creatorcontrib>Stiru, Ovidiu</creatorcontrib><creatorcontrib>Dragos, Dorin</creatorcontrib><creatorcontrib>Olaru, Octavian Gabriel</creatorcontrib><title>Continuous glucose monitoring devices: A brief presentation (Review)</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>As diabetes prevalence is continuously increasing, better management is needed to achieve blood glucose control, in order to prevent complications and lessen the burden of this disease. Since the first measurement of glycosuria at the beginning of the 1900s', huge advances were made in monitoring glycemia. Continuous glucose monitoring systems revolutionized diabetes management, especially for patients with type 1 diabetes. Avoiding glycemic variability and maintaining optimal glycemic control is crucial for the evolution of patients with type 1 diabetes. The usefulness of glycemic monitoring devices can be extended to patients with type 2 diabetes. It is also important to note that in those patients at risk of developing high glycemic variability (e.g. patients with advanced chronic kidney disease), continuous glycemic monitoring may improve their prognosis. These monitoring systems can be classified according to the analytical method, the degree of invasiveness, the data availability and the mode of usage. The technology is constantly improving in bioanalytical performance, biocompatibility, length of wearing time, safety and clinical features. The aim of this review was to briefly present the main characteristics of glucose biosensors, glucose monitoring systems and their clinically utility.</description><subject>Acids</subject><subject>Biosensors</subject><subject>Blood sugar monitoring</subject><subject>Diabetes</subject><subject>Electrodes</subject><subject>Enzymes</subject><subject>Glucose monitoring</subject><subject>Glucose monitors</subject><subject>Graphene</subject><subject>Methods</subject><subject>Nanoparticles</subject><subject>Physiology</subject><subject>Review</subject><subject>Sensors</subject><subject>Technology application</subject><subject>Urine</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNptkctLXDEUxoO0VLFuu5QL3bSLGfO4eXUhDOOjgiBIXYfc3JNpZG4yJvda-t8b66gVzFkknPOdjy_8EPpC8JwpTY9gHOYUUzInBGu5g_aI1HRGMOEftm-sFdlFB6Xc4nq4IErxT2iXcSy04nwPnSxTHEOc0lSa1XpyqUAzpBjGlENcNT3cBwflR7NouhzAN5sMBeJox5Bi8-26juHP98_oo7frAgfbex_dnJ3-Wv6cXV6dXywXlzPXEj7OpNMWhO28Vy1lTOqOY0o57ZkQXnIFVHvZug7LtueedJgK0lOtLSHgQHO2j46ffDdTN0DvapBs12aTw2DzX5NsMG8nMfw2q3RvlBQtV201-Lo1yOlugjKa2zTlWDMbKihTTAopX1UruwYTok_VzA2hOLMQNQZvFdNVNX9HVauHIbgUwYfaf2_B5VRKBv8SnGDzyNNUnuaRp_nHsy4c_v_dF_kzPfYAjzOaUA</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Mihai, Doina Andrada</creator><creator>Stefan, Diana Simona</creator><creator>Stegaru, Daniela</creator><creator>Bernea, Georgiana Elena</creator><creator>Vacaroiu, Ileana Adela</creator><creator>Papacocea, Toma</creator><creator>Lupușoru, Mircea Ovidiu Denis</creator><creator>Nica, Adriana Elena</creator><creator>Stiru, Ovidiu</creator><creator>Dragos, Dorin</creator><creator>Olaru, Octavian Gabriel</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20220201</creationdate><title>Continuous glucose monitoring devices: A brief presentation (Review)</title><author>Mihai, Doina Andrada ; Stefan, Diana Simona ; Stegaru, Daniela ; Bernea, Georgiana Elena ; Vacaroiu, Ileana Adela ; Papacocea, Toma ; Lupușoru, Mircea Ovidiu Denis ; Nica, Adriana Elena ; Stiru, Ovidiu ; Dragos, Dorin ; Olaru, Octavian Gabriel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-7c9ae6abff8423379b502252d366f758e29f74cb074d5f1b0261d299a11ece953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acids</topic><topic>Biosensors</topic><topic>Blood sugar monitoring</topic><topic>Diabetes</topic><topic>Electrodes</topic><topic>Enzymes</topic><topic>Glucose monitoring</topic><topic>Glucose monitors</topic><topic>Graphene</topic><topic>Methods</topic><topic>Nanoparticles</topic><topic>Physiology</topic><topic>Review</topic><topic>Sensors</topic><topic>Technology application</topic><topic>Urine</topic><toplevel>online_resources</toplevel><creatorcontrib>Mihai, Doina Andrada</creatorcontrib><creatorcontrib>Stefan, Diana Simona</creatorcontrib><creatorcontrib>Stegaru, Daniela</creatorcontrib><creatorcontrib>Bernea, Georgiana Elena</creatorcontrib><creatorcontrib>Vacaroiu, Ileana Adela</creatorcontrib><creatorcontrib>Papacocea, Toma</creatorcontrib><creatorcontrib>Lupușoru, Mircea Ovidiu Denis</creatorcontrib><creatorcontrib>Nica, Adriana Elena</creatorcontrib><creatorcontrib>Stiru, Ovidiu</creatorcontrib><creatorcontrib>Dragos, Dorin</creatorcontrib><creatorcontrib>Olaru, Octavian Gabriel</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mihai, Doina Andrada</au><au>Stefan, Diana Simona</au><au>Stegaru, Daniela</au><au>Bernea, Georgiana Elena</au><au>Vacaroiu, Ileana Adela</au><au>Papacocea, Toma</au><au>Lupușoru, Mircea Ovidiu Denis</au><au>Nica, Adriana Elena</au><au>Stiru, Ovidiu</au><au>Dragos, Dorin</au><au>Olaru, Octavian Gabriel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Continuous glucose monitoring devices: A brief presentation (Review)</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>23</volume><issue>2</issue><spage>174</spage><pages>174-</pages><artnum>174</artnum><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>As diabetes prevalence is continuously increasing, better management is needed to achieve blood glucose control, in order to prevent complications and lessen the burden of this disease. Since the first measurement of glycosuria at the beginning of the 1900s', huge advances were made in monitoring glycemia. Continuous glucose monitoring systems revolutionized diabetes management, especially for patients with type 1 diabetes. Avoiding glycemic variability and maintaining optimal glycemic control is crucial for the evolution of patients with type 1 diabetes. The usefulness of glycemic monitoring devices can be extended to patients with type 2 diabetes. It is also important to note that in those patients at risk of developing high glycemic variability (e.g. patients with advanced chronic kidney disease), continuous glycemic monitoring may improve their prognosis. These monitoring systems can be classified according to the analytical method, the degree of invasiveness, the data availability and the mode of usage. The technology is constantly improving in bioanalytical performance, biocompatibility, length of wearing time, safety and clinical features. The aim of this review was to briefly present the main characteristics of glucose biosensors, glucose monitoring systems and their clinically utility.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>35069855</pmid><doi>10.3892/etm.2021.11097</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-0981
ispartof Experimental and therapeutic medicine, 2022-02, Vol.23 (2), p.174, Article 174
issn 1792-0981
1792-1015
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8764584
source PubMed Central
subjects Acids
Biosensors
Blood sugar monitoring
Diabetes
Electrodes
Enzymes
Glucose monitoring
Glucose monitors
Graphene
Methods
Nanoparticles
Physiology
Review
Sensors
Technology application
Urine
title Continuous glucose monitoring devices: A brief presentation (Review)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T06%3A46%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Continuous%20glucose%20monitoring%20devices:%20A%20brief%20presentation%20(Review)&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Mihai,%20Doina%20Andrada&rft.date=2022-02-01&rft.volume=23&rft.issue=2&rft.spage=174&rft.pages=174-&rft.artnum=174&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2021.11097&rft_dat=%3Cgale_pubme%3EA695354839%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2623837677&rft_id=info:pmid/35069855&rft_galeid=A695354839&rfr_iscdi=true